1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Multiple Myeloma Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Multiple Myeloma Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • May 2018
  • 100 pages
  • ID: 5442010
  • Format: PDF
  • Infinium
Up to $1439 off Until Jun 10th 2020


Table of Contents

The report on global multiple myeloma market provides qualitative and quantitative analysis for the period of 2016 to 2026.

The report predicts the global multiple myeloma market to grow with a CAGR of 9.2% over the forecast period of 2018-2024. The study on multiple myeloma market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2026.
Multiple Myeloma is a type of cancer that is formed by malignant plasma cells. The normal plasma cells are mostly found in bone marrow and are thus an important part of the immune system. Multiple myeloma causes cancer cells to accumulate in the bone marrow, wherein they crowd out healthy blood cells. Rather than producing helpful antibodies, the cancer cells produce abnormal proteins that can cause complications.
Multiple Myeloma Drugs market was worth around XX million in 2017 and is anticipated to reach around XX million around 2024, in terms of revenue. Growing cases of plasma cancer across the globe due to exposure to harmful radiations or chemical, immune disorders or family history of the disease. Increased utilization of stem cell transplants and other new therapies. Also, development of novel drugs coupled with use of imaging technologies for disease assessment to augment the growth for the multiple myeloma drugs. These aforementioned factors are primarily responsible to drive the multiple myeloma drugs market. However, high treatment cost affects the multiple myeloma market, According to a study there is considerable population that is still not able to afford multiple myeloma cancer treatment. The development of new drugs and investment in research and development projects by government and non-government organizations is further expected to boost the market growth.
Among the regions, North America accounted for the dominant share in 2017. U.S primarily drives the North America multiple myeloma market, on account of presence of major multiple myeloma drugs manufacturing companies and their efforts in developing novel products to treat multiple myeloma cancer. Furthermore, factors such as increased healthcare infrastructure and improved healthcare reimbursement policies too are responsible to augment multiple myeloma drug market. Asia Pacific is expected to grow at the highest CAGR during the forecast period ,2018-2024 on account of huge population base, that in turn increases the chances of more number of people being affected with multiple myeloma market and increased government initiatives to assist people affected with cancer disease.

The report on multiple myeloma market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global multiple myeloma market over the period of 2016 to 2026. Moreover, the report is collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global multiple myeloma market over the period of 2016 to 2026. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global multiple myeloma market is segmented on the basis of drug type and distribution channel.

Global Multiple Myeloma Market by Drug Type
- Immunomodulating Agents
- Proteasome Inhibitors
- Histone Deacetylase (HDAC) Inhibitors
- Monoclonal Antibodies
- Others
Global Multiple Myeloma Market by Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Channel

Company Profiles
- Onyx Pharmaceuticals
- Bristol-Myers Squibb
- Novartis
- Pfizer
- Johnson and Johnson
- Celgene Corporation
- Takeda Pharmaceuticals

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of multiple myeloma market.
2. Complete coverage of all the segments in multiple myeloma market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global multiple myeloma market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on